Tech-enabled pharma marketing strategies
Palm trees bend and sway in hurricane-force winds that could topple an oak or crack the trunk of a sturdy pine. There’s a lesson...
Improving the patient treatment pathway
A clear, appropriate and best practice-based patient treatment pathway is crucial. Explore how to review an existing pathway to identify improvements.
At a time of...
Exploring spin-offs as a strategic option
The aim, typically, of spin-offs is to enhance the value of both the spin-off and parent company in relation to assets, employees, intellectual property,...
The AHSN Network and the importance of innovation
Innovation in healthcare has been essential to the NHS Covid-19 response. The government’s new vision for UK life sciences also recognises its importance in...
Mental health & COVID-19: Investing in technology
Dr Simon Bourne, founder and CEO of my mhealth, shares why he thinks investing in technology is essential to helping the nation rebuild its...
Could cannabis be crucial to the opioid crisis?
With the rise in awareness of the extent and implications of opioid misuse, alternative treatments are now more commonly considered for chronic pain control....
COVID: A new wave of interest in pharma, what learnings can we take into...
My Mum, Mary, aged 73, is a retired hairdresser, and this past year she’s discovered a new passion. Medical science. COVID-19 hasn’t left the...
Why the ABPI Code Principles matter
This week, the updated ABPI Code has been published, alongside a clear set of ABPI Principles. Here, Ben Osborn, President of the ABPI, explains...
From porsches to pacemakers: what healthcare can learn from automotive supply chains
How can automotive supply chains improve healthcare logistics? James Wells, UK International Freight Manager at Aramex explores the transferable practices that automotive manufacturers follow,...
Behaviour change campaigns in pharma
For pharma companies looking to execute behaviour change campaigns, understanding how to influence small shifts in our actions and attitudes will result in much...
Latest articles
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Nykode Therapeutics partners with Regeneron to develop innovative vaccines
Nykode Therapeutics (formerly Vaccibody) has entered into a collaboration agreement with Regeneron to develop innovative vaccines against cancer and infectious diseases. The agreement includes five...
New depression treatment options from NICE
The National Institute for Health and Care Excellence (NICE) has created a new menu of treatment options for those living with depression. It is the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
Four rooms of change: managing transition
For the UK pharma industry, 2010 is likely to bring change in various forms. How will you cope? OTD’s Andy Cotty explains how, with...
New COVID-19 test reduces testing time from 30 minutes to five
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, whilst still delivering accurate results. The...
5 hobbies you need on your CV
To list hobbies, or not to list hobbies? That is the question when it comes to CVs. But in fact, your interests say a...